Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019
- PMID: 35044047
- PMCID: PMC9303967
- DOI: 10.1111/bju.15688
Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019
Abstract
Objectives: To analyse the incidence, treatment strategies and complications associated with penile intraepithelial neoplasia (PeIN) in Sweden over a period of 20 years.
Materials and methods: Data on PeIN from the Swedish National Penile Cancer Register were analysed regarding treatment in relation to age, size of the PeIN lesion, localization of the PeIN lesion and complications using chi-squared tests and logistic regression. The incidence of PeIN was calculated and age-standardized according to the European Standard population.
Results: Between 2000 and 2019 a total of 1113 PeIN cases were reported. The age-standardized incidence of PeIN was 1.40 per 100 000 men (95% confidence interval [CI] 1.32-1.49). An increase in incidence over time was seen, with a standardized incidence rate of 2.37 (95% CI 1.56-3.70) in 2019 compared to the baseline year, 2000. Surgical or topical treatments were given in 75.0% and 14.6% of cases, respectively. The complication rate was higher in laser surgery (12.1%, 7/58) compared to local surgery (4.6%, 16/348; P = 0.03) with an age-adjusted odds ratio (OR) of 2.82 (95% CI 1.10-7.19; P = 0.03). Local surgery was more common than laser surgery in the last 5 years compared to the first 5 years of the study period: OR 5.75 (95% CI 2.94-11.27). Treatments with imiquimod and topical 5-fluorouracil (5-FU) were more common than destructive methods such as photodynamic therapy, cryotherapy, curettage and electrocautery in the last 5 years compared to the first 5 years: OR 9.48 (95% CI 2.29-39.24).
Conclusions: A twofold increase in the age-standardized incidence of PeIN was seen in Sweden over 20 years. Complications were three times more common in laser surgery compared to local surgery. Changes in treatment showed an increase of treatment strategies such as local surgery and treatment with imiquimod and topical 5-FU over time.
Keywords: #PenileCancer; #uroonc; incidence; penile cancer; penile intraepithelial neoplasia; treatment.
© 2022 The Authors. BJU International published by John Wiley & Sons Ltd on behalf of BJU International.
Conflict of interest statement
None declared.
Figures
References
-
- Curado MP, Edwards B, Shin HR et al. Cancer Incidence in Five Continents. Lyon, France: IARC, 2007. Contract No.: 160
-
- Kirrander P, Sherif A, Friedrich B, Lambe M, Hakansson U. Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival. BJU Int 2016; 117: 287–92 - PubMed
-
- Graafland NM, Verhoeven RH, Coebergh JW, Horenblas S. Incidence trends and survival of penile squamous cell carcinoma in The Netherlands. Int J Cancer 2011; 128: 426–32 - PubMed
-
- Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs‐part a: renal, penile, and testicular tumours. Eur Urol 2016; 70: 93–105 - PubMed
-
- Kristiansen S, Svensson A, Drevin L, Forslund O, Torbrand C, Bjartling C. Risk factors for penile intraepithelial neoplasia: a population‐based register study in Sweden, 2000‐2012. Acta Derm Venereol 2019; 99: 315–20 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources